💨 Abstract

Eli Lilly plans to launch its blockbuster diabetes drug, Mounjaro, in countries such as China, India, Brazil, and Mexico in 2025, as announced by the company's Chief Financial Officer Lucas Montarce at the Leerink Partners Global Healthcare Conference.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖

Powered by MessengerX.io